Septerna Emerges With $100m To Target Undruggable GPCRs

Start-Up Pairs Structural Insights With Computational Tools

 
• By Mandy Jackson
  
Start up concept vector illustration
The start-up is screening GPCR-targeting compounds at scale • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business